company background image
6797 logo

Taiwan Advanced Nanotech TPEX:6797 Stock Report

Last Price

NT$28.80

Market Cap

NT$877.8m

7D

-0.5%

1Y

-50.5%

Updated

15 Apr, 2024

Data

Company Financials

Taiwan Advanced Nanotech Inc.

TPEX:6797 Stock Report

Market Cap: NT$877.8m

6797 Stock Overview

Taiwan Advanced Nanotech Inc. designs and manufactures products for nucleic acid purification.

6797 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends2/6

Taiwan Advanced Nanotech Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Taiwan Advanced Nanotech
Historical stock prices
Current Share PriceNT$28.80
52 Week HighNT$63.80
52 Week LowNT$27.50
Beta0.63
1 Month Change-0.69%
3 Month Change-20.44%
1 Year Change-50.52%
3 Year Change-88.87%
5 Year Changen/a
Change since IPO-88.45%

Recent News & Updates

Recent updates

Taiwan Advanced Nanotech's (GTSM:6797) Solid Profits Have Weak Fundamentals

Apr 08
Taiwan Advanced Nanotech's (GTSM:6797) Solid Profits Have Weak Fundamentals

Should We Be Delighted With Taiwan Advanced Nanotech Inc.'s (GTSM:6797) ROE Of 24%?

Feb 10
Should We Be Delighted With Taiwan Advanced Nanotech Inc.'s (GTSM:6797) ROE Of 24%?

Shareholder Returns

6797TW Medical EquipmentTW Market
7D-0.5%-0.3%1.8%
1Y-50.5%4.3%28.5%

Return vs Industry: 6797 underperformed the TW Medical Equipment industry which returned 4.3% over the past year.

Return vs Market: 6797 underperformed the TW Market which returned 28.5% over the past year.

Price Volatility

Is 6797's price volatile compared to industry and market?
6797 volatility
6797 Average Weekly Movement2.9%
Medical Equipment Industry Average Movement4.4%
Market Average Movement4.4%
10% most volatile stocks in TW Market8.2%
10% least volatile stocks in TW Market2.0%

Stable Share Price: 6797's share price has been volatile over the past 3 months.

Volatility Over Time: 6797's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004n/aRaman Chienwww.tanbead.com

Taiwan Advanced Nanotech Inc. designs and manufactures products for nucleic acid purification. The company’s products include reagent kits, which are used in DNA/RNA extractions from samples of blood, cell, tissue, plant, bacteria, virus, etc.; magnetic nanoparticles, including super-paramagnetic iron oxide and ultra small super-paramagnetic iron oxide for molecular biology applications; automated extraction instruments; and consumables, such as spin tips and deep well plates. It offers its products to disease control centers, testing institutions, hospitals, and other related facilities.

Taiwan Advanced Nanotech Inc. Fundamentals Summary

How do Taiwan Advanced Nanotech's earnings and revenue compare to its market cap?
6797 fundamental statistics
Market capNT$877.83m
Earnings (TTM)-NT$159.44m
Revenue (TTM)NT$398.37m

2.2x

P/S Ratio

-5.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6797 income statement (TTM)
RevenueNT$398.37m
Cost of RevenueNT$389.67m
Gross ProfitNT$8.70m
Other ExpensesNT$168.14m
Earnings-NT$159.44m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-5.23
Gross Margin2.18%
Net Profit Margin-40.02%
Debt/Equity Ratio19.5%

How did 6797 perform over the long term?

See historical performance and comparison

Dividends

10.4%

Current Dividend Yield

-57%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.